Ciprofloxacin
Brand names: Cipro, Cipro XR, Proquin XR
Fluoroquinolone AntibioticsKey Takeaway
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
⚠ FDA Black Box Warning
**Tendon Rupture and Tendinitis:** Fluoroquinolones, including ciprofloxacin, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients (usually over 60 years of age), in patients taking corticosteroid drugs, and in patients with kidney, heart, or lung transplants. Discontinue if tendon pain, swelling, or inflammation occurs.
**Peripheral Neuropathy:** Fluoroquinolones, including ciprofloxacin, have been associated with an increased risk of peripheral neuropathy. Symptoms may occur soon after initiation and may be irreversible. Discontinue immediately if symptoms of peripheral neuropathy occur.
**Central Nervous System Effects:** Fluoroquinolones have been associated with an increased risk of central nervous system effects including convulsions, increased intracranial pressure, tremors, and toxic psychosis. Use with caution in patients with known or suspected CNS disorders.
**Exacerbation of Myasthenia Gravis:** Fluoroquinolones have neuromuscular blocking activity and may exacerbate muscle weakness in patients with myasthenia gravis. Avoid in patients with a known history of myasthenia gravis.
Emergency Information
Poison Control: 1-800-222-1222
How does Ciprofloxacin work?
Ciprofloxacin belongs to the fluoroquinolone class of antibiotics, which work by targeting two essential bacterial enzymes: DNA gyrase (topoisomerase II) and topoisomerase IV [1]. These enzymes are critical for bacterial DNA replication, transcription, and repair.
When ciprofloxacin binds to these enzymes, it forms a drug-enzyme-DNA complex that prevents the bacterial DNA from being properly unwound and replicated [2]. This leads to double-strand DNA breaks and ultimately kills the bacterial cell. Unlike some antibiotics that merely stop bacteria from growing, ciprofloxacin is bactericidal — it actively kills bacteria rather than just inhibiting their growth.
Ciprofloxacin has a broad spectrum of activity covering many gram-negative organisms (such as *E. coli*, *Pseudomonas aeruginosa*, and *Klebsiella*) and some gram-positive organisms [3]. However, increasing resistance among *E. coli* and other uropathogens has reduced its empiric utility for uncomplicated UTIs in many regions. The Infectious Diseases Society of America now recommends fluoroquinolones be reserved for situations where other agents cannot be used [4].
The drug exhibits concentration-dependent killing, meaning higher peak concentrations relative to the minimum inhibitory concentration (MIC) produce more effective bacterial killing [5].
What to expect when starting Ciprofloxacin
When starting ciprofloxacin, most patients begin to notice improvement in their infection symptoms within 2-3 days, though it is essential to complete the full prescribed course [1].
During the first few days, you may experience mild nausea, diarrhea, or an upset stomach. Taking the medication with a light meal (but not dairy products or calcium-fortified foods) can help minimize GI side effects. Drink plenty of water to stay well hydrated, as ciprofloxacin can crystallize in concentrated urine [3].
You should avoid direct sunlight and tanning beds during treatment, as ciprofloxacin increases sun sensitivity. Use SPF 30+ sunscreen and protective clothing when outdoors [1].
Be alert for tendon pain or swelling — particularly in the Achilles tendon — and stop the medication immediately and contact your doctor if this occurs. Also report any tingling, numbness, or burning sensations in your hands or feet, which could indicate peripheral neuropathy [4].
What are the common side effects of Ciprofloxacin?
Common
- Nausea5.2%
- Diarrhea4.8%
- Headache3.5%
- Abdominal pain2.5%
- Rash1.8%
- Dizziness1.5%
- Insomnia1.3%
- Vomiting1.2%
- Dyspepsia1.0%
- Photosensitivity0.8%
What are the serious side effects of Ciprofloxacin?
Serious
- Tendon rupture or tendinitis
- Peripheral neuropathy
- CNS effects (seizures, psychosis)
- Clostridioides difficile-associated diarrhea
- Aortic aneurysm or dissection
- QT prolongation
What drugs interact with Ciprofloxacin?
- MajorTizanidine — Concomitant use is contraindicated. Ciprofloxacin inhibits CYP1A2, causing dramatic increases in tizanidine levels (up to 10-fold), leading to severe hypotension and sedation.
- MajorWarfarin — Ciprofloxacin can significantly increase warfarin levels by inhibiting CYP1A2, increasing bleeding risk. Monitor INR closely if coadministration is necessary.
- MajorTheophylline — Ciprofloxacin inhibits CYP1A2 metabolism of theophylline, potentially causing theophylline toxicity (seizures, cardiac arrhythmias). Monitor theophylline levels.
- MajorAntacids (aluminum/magnesium) — Metal cation chelation reduces ciprofloxacin absorption by up to 90%. Administer ciprofloxacin at least 2 hours before or 6 hours after antacids.
- ModerateCyclosporine — Ciprofloxacin may increase cyclosporine serum levels and nephrotoxicity risk. Monitor renal function and cyclosporine levels.
- ModerateMethotrexate — Ciprofloxacin may inhibit renal tubular secretion of methotrexate, increasing methotrexate levels and toxicity risk. Monitor for methotrexate adverse effects.
- ModerateNSAIDs — Concurrent use may increase the risk of CNS stimulation and seizures. Use with caution.
- ModerateDuloxetine — Ciprofloxacin is a potent CYP1A2 inhibitor and can significantly increase duloxetine exposure. Avoid combination when possible.
Can I eat certain foods or drink alcohol with Ciprofloxacin?
Food Interactions: Ciprofloxacin should be taken 2 hours before or 6 hours after consuming dairy products, calcium-fortified juices, or foods high in calcium, magnesium, or iron [1]. These minerals form insoluble chelates with ciprofloxacin, reducing absorption by up to 90%. Taking ciprofloxacin with a regular meal (not high in minerals) is acceptable and may reduce GI side effects.
Caffeine: Ciprofloxacin inhibits CYP1A2, the primary enzyme responsible for caffeine metabolism. This can increase caffeine levels by 15-40%, potentially causing jitteriness, insomnia, and increased heart rate [2]. Consider reducing caffeine intake during treatment.
Alcohol: While there is no absolute contraindication, alcohol may worsen ciprofloxacin side effects such as dizziness, drowsiness, and GI upset. Alcohol can also impair immune function during active infection [3]. It is generally advisable to avoid alcohol during antibiotic therapy.
Hydration: Adequate fluid intake is important during ciprofloxacin therapy to prevent crystalluria (drug crystals in the urine), particularly in alkaline urine [1].
What is the typical dosage for Ciprofloxacin?
Urinary Tract Infections (uncomplicated): 250 mg orally every 12 hours for 3 days, or 500 mg extended-release once daily for 3 days [1].
Urinary Tract Infections (complicated): 500 mg orally every 12 hours for 7-14 days [1].
Respiratory Tract Infections: 500-750 mg orally every 12 hours for 7-14 days, depending on severity and pathogen [1].
Skin and Soft Tissue Infections: 500-750 mg orally every 12 hours for 7-14 days [1].
Bone and Joint Infections: 500-750 mg orally every 12 hours for 4-8 weeks [1].
Inhalational Anthrax (post-exposure): 500 mg orally every 12 hours for 60 days [3].
Renal Dose Adjustment: For CrCl 30-50 mL/min, no adjustment needed for most indications. For CrCl 5-29 mL/min, reduce dose to 250-500 mg every 18 hours [1].
Administration: Take with a full glass of water. Avoid taking with dairy products or calcium-fortified foods. Separate from antacids by at least 2 hours before or 6 hours after.
How much does Ciprofloxacin cost?
Generic ciprofloxacin is widely available and significantly less expensive than brand-name Cipro. A typical 14-day course of generic ciprofloxacin 500 mg tablets costs approximately $10-20 at most pharmacies, compared to $200+ for brand-name Cipro [6].
Cost-saving strategies: - Generic substitution: Generic ciprofloxacin has been available since 2004 and is therapeutically equivalent (FDA "AB" rated) [1] - Pharmacy discount programs: Many chains (Walmart, Costco, grocery stores) include ciprofloxacin on their $4/$10 generic drug lists - GoodRx or RxSaver coupons: Can reduce out-of-pocket costs to $4-8 for a typical course - 90-day mail order: For patients on suppressive therapy, mail-order pharmacies may offer additional savings - Avoid extended-release formulations when immediate-release is appropriate, as XR formulations may cost more
Is Ciprofloxacin safe during pregnancy or breastfeeding?
Pregnancy (Category C): Ciprofloxacin crosses the placenta. Animal studies have shown arthropathy (joint damage) in immature animals, and fluoroquinolones are generally not recommended during pregnancy due to the theoretical risk of cartilage damage in the developing fetus [1]. Use only if the potential benefit justifies the potential risk, and no safer alternative exists.
Breastfeeding: Ciprofloxacin is excreted in breast milk. The American Academy of Pediatrics considers it a drug whose effect on nursing infants is unknown but may be of concern [7]. There is a theoretical risk of arthropathy and alteration of infant gut flora. If ciprofloxacin must be used, consider pumping and discarding milk during treatment and for 48 hours after the last dose.
Pediatric Use: Ciprofloxacin is FDA-approved for children for specific indications (complicated UTI, inhalational anthrax) but is generally avoided in pediatric patients due to musculoskeletal concerns. However, the AAP notes that the risk of joint damage appears lower than initially feared [8].
Is there a generic version of Ciprofloxacin?
Generic ciprofloxacin has been available in the United States since 2004, when the patent for brand-name Cipro expired. The FDA rates generic ciprofloxacin as therapeutically equivalent ("AB" rating) to the brand product, meaning it has demonstrated the same active ingredient, strength, dosage form, and bioequivalence [1].
Today, over 99% of ciprofloxacin prescriptions are filled with generic versions. Brand-name Cipro has been effectively discontinued by the manufacturer for most formulations. There is no clinically meaningful difference between generic and brand ciprofloxacin in terms of efficacy, safety, or tolerability.
The extended-release formulation (Cipro XR) also has generic equivalents available, though at somewhat higher cost than the immediate-release tablets.
For Caregivers
For caregivers monitoring a patient on ciprofloxacin:
- Watch for tendon problems: Ask about and observe for signs of tendon pain, swelling, or difficulty walking — especially in the Achilles tendon area. Risk is highest in patients over 60 and those also taking corticosteroids. Stop the medication and call the doctor immediately if these occur. - Monitor for nerve symptoms: Watch for complaints of tingling, numbness, or burning in the hands or feet, which may indicate peripheral neuropathy. - Ensure proper timing: Help the patient take ciprofloxacin at consistent 12-hour intervals and separate from antacids, dairy products, and mineral supplements by at least 2 hours before or 6 hours after. - Hydration: Encourage adequate fluid intake (at least 6-8 glasses of water daily) to prevent kidney crystallization. - Mental health monitoring: Be alert for unusual mood changes, confusion, hallucinations, or signs of depression, which can occur with fluoroquinolones.
Frequently asked questions about Ciprofloxacin
References
- [Regulatory] Cipro (ciprofloxacin hydrochloride) [prescribing information]. Bayer HealthCare Pharmaceuticals Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019537s086,020780s043lbl.pdf Accessed 2026-02-15.
- [Clinical] Hooper DC, Jacoby GA. Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci. 2015;1354(1):12-31. https://pubmed.ncbi.nlm.nih.gov/26190223/ Accessed 2026-02-15.
- [Regulatory] FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects (2016). https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics Accessed 2026-02-15.
- [Clinical] Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women. Clin Infect Dis. 2011;52(5):e103-e120. https://pubmed.ncbi.nlm.nih.gov/21292654/ Accessed 2026-02-15.
- [Clinical] Forrest A, Nix DE, Ballow CH, et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother. 1993;37(5):1073-1081. https://pubmed.ncbi.nlm.nih.gov/8517694/ Accessed 2026-02-15.
- [Regulatory] Ciprofloxacin - Drug Information. National Library of Medicine DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87395c5f-4d42-4542-8a15-5a03560a5b4e Accessed 2026-02-15.
- [Regulatory] Ciprofloxacin use during breastfeeding. Drugs and Lactation Database (LactMed). National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/30000262/ Accessed 2026-02-15.
- [Clinical] Bradley JS, Jackson MA; Committee on Infectious Diseases. The use of systemic and topical fluoroquinolones. Pediatrics. 2011;128(4):e1034-e1045. https://pubmed.ncbi.nlm.nih.gov/21949152/ Accessed 2026-02-15.
- [Regulatory] FDA Drug Safety Communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics (2018). https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics Accessed 2026-02-15.
- [Clinical] Pham TDM, Ziora ZM, Blaskovich MAT. Quinolone antibiotics. Medchemcomm. 2019;10(10):1719-1739. https://pubmed.ncbi.nlm.nih.gov/31803393/ Accessed 2026-02-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: